The new US position in support of lifting patents on COVID-19 vaccines has taken attention away from an equally significant change by Washington, which plans to open up trade in the raw materials used to make them.
The new US position in support of lifting patents on COVID-19 vaccines has taken attention away from an equally significant change by Washington, which plans to open up trade in the raw materials used to make them.
